$DLB

Dolby SVP Shriram Revankar sells $164,700 in company stock

Shriram Revankar, Senior Vice President at Dolby Laboratories, sold 3,000 shares of company stock for $164,700 on May 15, 2026, executed via a pre-arranged trading plan. This sale occurred while the stock was near its 52-week low, despite recent positive Q2 2026 earnings where Dolby surpassed EPS and revenue forecasts. The company also disposed of shares to cover withholding taxes, and Revankar now holds 76,274 shares including restricted stock units.

Original reporting
Investing.com · Investing.com
Published May 20, 2026, 5:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 20, 2026, 5:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dolby SVP Shriram Revankar sells $164,700 in company stock — source image
Decision brief

The 30-second read

$DLBBearishMed
01

Why it matters

The insider sale near a low point, despite good earnings, could be interpreted as cautious sentiment, but the pre-arranged nature of the sale limits negative implications.

02

Market read

The insider sale may cause short-term negative sentiment among investors, but the pre-arranged execution suggests limited impact on long-term outlook.

03

What to watch

The sale was executed via a pre-arranged plan, which may suggest planned liquidity rather than negative sentiment.

Timing: Immediate, as the insider sale occurred on May 15, 2026.

Background

Shriram Revankar, SVP at Dolby, sold 3,000 shares for $164,700 on May 15, 2026, via a pre-arranged plan, while the stock was near its 52-week low despite positive earnings.

Company-level read

Ticker impact

$DLBBearishMedium confidence
Context

The insider stock sale by Dolby's SVP is relevant to Dolby's stock performance and investor sentiment.

Expected impact

Moderate short-term decline expected, possibly 2-4% decrease in stock price.

Evidence & confidence

Insider sales near lows, despite positive earnings, can signal caution or personal liquidity needs, but the sale was executed via a pre-arranged plan, which may mitigate negative implications.

Market effects

Potential minor negative sentiment in the technology and audio equipment sectors.

Limited, primarily affecting US-based Dolby investors.

Minimal, as Dolby's market cap and global influence are moderate.

Counterpoint

Insider sales do not always indicate negative outlook; they could be for personal liquidity or diversification.

Key entities

  • Shriram Revankar

    Senior Vice President at Dolby Laboratories.

  • Dolby Laboratories

    A company specializing in audio and imaging technologies.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co